Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Mohammad I Abuabat

Showing results (1-10 of 7) with videos related to

Pageof 1
Sort By:
Diabetes Care|July 9, 2026
Detectable C-Peptide and Diabetic Ketoacidosis Risk in Type 1 DiabetesMohammad I Abuabat, Dalton Budhram, Priya Bapat, et al.
Canadian Journal of Diabetes|November 30, 2025
Barriers to Diabetic Ketoacidosis Prevention in Adults with Type 1 Diabetes: Implications for Education and Implementation of New Monitoring TechnologiesNatasha J Verhoeff, Wajeeha Cheema, Sara Mojdehi, et al.
Canadian Journal of Diabetes|July 28, 2024
Prognostic Implications of Diabetic Ketoacidosis in Adults on Long-term Mortality and Diabetes-Related ComplicationsDalton R Budhram, Priya Bapat, Abdulmohsen Bakhsh, et al.
Diabetes Technology & Therapeutics|October 10, 2024
Insulin Pump Use and Diabetic Ketoacidosis Risk in Type 1 Diabetes: Secular Trends over Four DecadesDalton R Budhram, Priya Bapat, Abdulmohsen Bakhsh, et al.
Diabetes Care|February 14, 2025
Longitudinal Determination of Diabetes Complications and Other Clinical Variables as Risk Factors for Diabetic Ketoacidosis in Type 1 DiabetesPriya Bapat, Dalton R Budhram, Abdulmohsen Bakhsh, et al.
Canadian Journal of Diabetes|November 9, 2023
Fasted C-Peptide Distribution and Associated Clinical Factors in Adults With Longstanding Type 1 Diabetes: Analysis of the Canadian Study of Longevity in Type 1 DiabetesSebastien O Lanctôt, Leif Erik Lovblom, Evan J H Lewis, et al.
Diabetes Care|January 27, 2026
Chronic Kidney Disease and Risk of Diabetic Ketoacidosis in Type 1 DiabetesAbdulmohsen Bakhsh, Aman Saleemi, Dalton Budhram, et al.
Pageof 1

Showing results (1-10 of 7) with videos related to

Sort By:
Pageof 1
Diabetes Care|July 9, 2026
Detectable C-Peptide and Diabetic Ketoacidosis Risk in Type 1 DiabetesMohammad I Abuabat, Dalton Budhram, Priya Bapat, et al.
Canadian Journal of Diabetes|November 30, 2025
Barriers to Diabetic Ketoacidosis Prevention in Adults with Type 1 Diabetes: Implications for Education and Implementation of New Monitoring TechnologiesNatasha J Verhoeff, Wajeeha Cheema, Sara Mojdehi, et al.
Canadian Journal of Diabetes|July 28, 2024
Prognostic Implications of Diabetic Ketoacidosis in Adults on Long-term Mortality and Diabetes-Related ComplicationsDalton R Budhram, Priya Bapat, Abdulmohsen Bakhsh, et al.
Diabetes Technology & Therapeutics|October 10, 2024
Insulin Pump Use and Diabetic Ketoacidosis Risk in Type 1 Diabetes: Secular Trends over Four DecadesDalton R Budhram, Priya Bapat, Abdulmohsen Bakhsh, et al.
Diabetes Care|February 14, 2025
Longitudinal Determination of Diabetes Complications and Other Clinical Variables as Risk Factors for Diabetic Ketoacidosis in Type 1 DiabetesPriya Bapat, Dalton R Budhram, Abdulmohsen Bakhsh, et al.
Canadian Journal of Diabetes|November 9, 2023
Fasted C-Peptide Distribution and Associated Clinical Factors in Adults With Longstanding Type 1 Diabetes: Analysis of the Canadian Study of Longevity in Type 1 DiabetesSebastien O Lanctôt, Leif Erik Lovblom, Evan J H Lewis, et al.
Diabetes Care|January 27, 2026
Chronic Kidney Disease and Risk of Diabetic Ketoacidosis in Type 1 DiabetesAbdulmohsen Bakhsh, Aman Saleemi, Dalton Budhram, et al.
Pageof 1